<font color="blue">[_1</font> <font color="blue">Limbal_3</font> <font color="blue">epithelial_3</font> <font color="blue">autograft_2</font> <font color="blue">transplantation_2</font> in treatment of <font color="blue">pterygium_1</font> <font color="blue">]_1</font> . 
<br>
<br> OBJECTIVE To observe the <font color="blue">therapeutic_1</font> <font color="blue">effects_1</font> of <font color="blue">limbal_2</font> <font color="blue">epithelial_2</font> <font color="blue">autograft_2</font> <font color="blue">transplantation_1</font> <font color="blue">and_1</font> <font color="blue">pterygium_2</font> <font color="blue">excision_2</font> in the treatment of <font color="blue">pterygium_1</font> <font color="blue">._1</font> 
<br> METHODS A prospective randomized paired - eye trial was studied . There were 208 patients ( 229 eyes ) with initial pterygium , and they were allocated to two groups : <font color="blue">excision_3</font> <font color="blue">of_3</font> <font color="blue">pterygium_4</font> <font color="blue">with_3</font> <font color="blue">limbal_4</font> <font color="blue">epithelial_4</font> <font color="blue">autograft_3</font> <font color="blue">transplantation_3</font> <font color="blue">surgery_3</font> ( A group , 106 cases and 124 eyes ) and <font color="blue">simple_4</font> <font color="blue">pterygium_5</font> <font color="blue">excision_5</font> ( B group , 102 cases and 105 eyes ) . The criteria for recovery were corneal transparency with stable <font color="blue">epithelial_1</font> <font color="blue">healing_1</font> and no <font color="blue">abnormal_1</font> <font color="blue">proliferation_1</font> of <font color="blue">pterygium_1</font> <font color="blue">-_1</font> like tissue . The post - operative follow - up periods ranged from 18 approximately 28 ( 22.4 + /- 4.9 ) months . 
<br> RESULTS Some of the patients lost follow - up . In the eyes followed up , 5 of 11 2 eyes ( 4.5% ) in A group and 41 of 96 eyes ( 42.7% ) in B group were recurred , the difference being very significant ( P < 0.001 ) . 
<br> CONCLUSION To provide a new stem cell source , <font color="blue">limbal_2</font> <font color="blue">epithelial_2</font> <font color="blue">autograft_1</font> <font color="blue">transplantation_1</font> <font color="blue">,_1</font> for an injured limb us is a reasonable <font color="blue">therapeutic_1</font> method for the treatment of <font color="blue">pterygium_1</font> <font color="blue">._1</font>